Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1970 1
1974 2
1975 10
1976 11
1977 16
1978 22
1979 21
1980 29
1981 82
1982 113
1983 141
1984 167
1985 213
1986 267
1987 241
1988 288
1989 320
1990 351
1991 409
1992 404
1993 430
1994 434
1995 486
1996 452
1997 447
1998 466
1999 437
2000 435
2001 442
2002 403
2003 411
2004 438
2005 391
2006 455
2007 466
2008 485
2009 421
2010 512
2011 501
2012 551
2013 524
2014 483
2015 530
2016 521
2017 501
2018 462
2019 467
2020 488
2021 539
2022 521
2023 504
2024 489
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

16,894 results

Results by year

Filters applied: . Clear all
Page 1
ApoB Is Ready for Prime Time.
Remaley AT, Cole J, Sniderman AD. Remaley AT, et al. J Am Coll Cardiol. 2024 Jun 11;83(23):2274-2275. doi: 10.1016/j.jacc.2024.04.008. J Am Coll Cardiol. 2024. PMID: 38839201 No abstract available.
ApoB versus non-HDL-C: what to do when they disagree.
Sniderman A, Williams K, Cobbaert C. Sniderman A, et al. Curr Atheroscler Rep. 2009 Sep;11(5):358-63. doi: 10.1007/s11883-009-0054-2. Curr Atheroscler Rep. 2009. PMID: 19664379 Review.
The high correlation between apolipoprotein B (apoB) and non-high-density lipoprotein cholesterol (non-HDL-C) is the chief argument employed against introducing apoB into clinical practice. ...These examples establish that apoB and non-HDL-C are not clinical …
The high correlation between apolipoprotein B (apoB) and non-high-density lipoprotein cholesterol (non-HDL-C) is the chief argument e …
Zebrafish ApoB-Containing Lipoprotein Metabolism: A Closer Look.
Moll TOC, Farber SA. Moll TOC, et al. Arterioscler Thromb Vasc Biol. 2024 May;44(5):1053-1064. doi: 10.1161/ATVBAHA.123.318287. Epub 2024 Mar 14. Arterioscler Thromb Vasc Biol. 2024. PMID: 38482694 Free article. Review.
Recent work revealed that any disturbance of lipoprotein formation leads to the accumulation of cytoplasmic lipid droplets and an opaque yolk, providing a visible phenotype to investigate disturbances of the lipoprotein pathway, already leading to discoveries in MTTP (microsomal …
Recent work revealed that any disturbance of lipoprotein formation leads to the accumulation of cytoplasmic lipid droplets and an opaque yol …
Standardization of Apolipoprotein B, LDL-Cholesterol, and Non-HDL-Cholesterol.
Contois JH, Langlois MR, Cobbaert C, Sniderman AD. Contois JH, et al. J Am Heart Assoc. 2023 Aug;12(15):e030405. doi: 10.1161/JAHA.123.030405. Epub 2023 Jul 25. J Am Heart Assoc. 2023. PMID: 37489721 Free PMC article. Review.
Concern continues about whether the measurement of apolipoprotein B (apoB) is adequately standardized, and therefore, whether apoB should be applied widely in clinical care. ...Multiple expert groups have determined that the measurement of apoB is adequately …
Concern continues about whether the measurement of apolipoprotein B (apoB) is adequately standardized, and therefore, whether apoB …
APOB and CCL17 as mediators in the protective effect of SGLT2 inhibition against myocardial infarction: Insights from proteome-wide mendelian randomization.
Shi L, Li G, Hou N, Tu L, Li J, Luo J, Hu S. Shi L, et al. Eur J Pharmacol. 2024 Aug 5;976:176619. doi: 10.1016/j.ejphar.2024.176619. Epub 2024 Apr 26. Eur J Pharmacol. 2024. PMID: 38679119
Among 4907 circulating proteins, we identified APOB and CCL17 which were related to both SGLT2 inhibition and MI. Mediation analysis showed evidence of the indirect effect of SGLT2 inhibition on MI through APOB (beta = -0.557, 95%CI [-1.098, -0.155]) with a mediated …
Among 4907 circulating proteins, we identified APOB and CCL17 which were related to both SGLT2 inhibition and MI. Mediation analysis …
Lipid transfer proteins in the assembly of apoB-containing lipoproteins.
Sirwi A, Hussain MM. Sirwi A, et al. J Lipid Res. 2018 Jul;59(7):1094-1102. doi: 10.1194/jlr.R083451. Epub 2018 Apr 12. J Lipid Res. 2018. PMID: 29650752 Free PMC article. Review.
A better understanding of intracellular lipoprotein assembly may help identify proteins with important roles in lipid disorders. apoB-containing lipoproteins (B-lps) are macromolecular lipid and protein micelles that act as specialized transport vehicles for hydrophobic li …
A better understanding of intracellular lipoprotein assembly may help identify proteins with important roles in lipid disorders. apoB …
Lipid disorders and mutations in the APOB gene.
Whitfield AJ, Barrett PH, van Bockxmeer FM, Burnett JR. Whitfield AJ, et al. Clin Chem. 2004 Oct;50(10):1725-32. doi: 10.1373/clinchem.2004.038026. Epub 2004 Aug 12. Clin Chem. 2004. PMID: 15308601 Free article. Review.
Apolipoprotein (apo) B is a large, amphipathic glycoprotein that plays a central role in human lipoprotein metabolism. Two forms of apoB are produced from the APOB gene by a unique posttranscriptional editing process: apoB-48, which is required for chylomicro …
Apolipoprotein (apo) B is a large, amphipathic glycoprotein that plays a central role in human lipoprotein metabolism. Two forms of apoB …
Microsomal triglyceride transfer protein and its role in apoB-lipoprotein assembly.
Hussain MM, Shi J, Dreizen P. Hussain MM, et al. J Lipid Res. 2003 Jan;44(1):22-32. doi: 10.1194/jlr.r200014-jlr200. J Lipid Res. 2003. PMID: 12518019 Free article. Review.
A novel antagonist that inhibits apoB-MTP binding decreases apoB secretion. Furthermore, site-directed mutagenesis and deletion analyses that inhibit apoB-MTP binding decrease apoB secretion. ...ApoB-MTP binding may be important for the preventi …
A novel antagonist that inhibits apoB-MTP binding decreases apoB secretion. Furthermore, site-directed mutagenesis and deletio …
Apolipoprotein B levels, APOB alleles, and risk of ischemic cardiovascular disease in the general population, a review.
Benn M. Benn M. Atherosclerosis. 2009 Sep;206(1):17-30. doi: 10.1016/j.atherosclerosis.2009.01.004. Epub 2009 Jan 15. Atherosclerosis. 2009. PMID: 19200547 Review.
The present review examines, with focus on general population studies, apolipoprotein B levels as a predictor of ischemic cardiovascular disease, as well as the association of mutations and polymorphisms in APOB with plasma apolipoprotein B levels, and risk of ischemic car …
The present review examines, with focus on general population studies, apolipoprotein B levels as a predictor of ischemic cardiovascular dis …
16,894 results
You have reached the last available page of results. Please see the User Guide for more information.